Intravenous vitamin C administration improves quality of life in breast cancer patients during chemo-/radiotherapy and aftercare: results of a retrospective, multicentre …

C Vollbracht, B Schneider, V Leendert, G Weiss… - in vivo, 2011 - iv.iiarjournals.org
Aim: The aim of the study was to evaluate under praxis conditions the safety and efficacy of
intravenous (iv) vitamin C administration in the first postoperative year of women with breast …

Prevention of venous thromboembolism after knee arthroscopy with low–molecular weight heparin (Reviparin): results of a randomized controlled trial

T Wirth, B Schneider, F Misselwitz, M Lomb… - … : The Journal of …, 2001 - Elsevier
Purpose: Deep venous thrombosis (DVT) is a common, important complication of major
orthopaedic surgery, particularly knee arthroplasty. Knee arthroscopy is increasingly performed …

[PDF][PDF] Efficacy and safety of long-term complementary treatment with standardized european mistletoe extract (Viscum album L.) in addition to the conventional …

…, J Hanisch, M Karasmann, B Schneider - Arzneimittel …, 2004 - researchgate.net
Objectives: The purpose of the study was to evaluate the therapeutic efficacy and safety of
long-term complementary therapy in primary, non-metastatic breast cancer patients in UICC …

The role of a homoeopathic preparation compared with conventional therapy in the treatment of injuries: an observational cohort study

C Schneider, B Schneider, J Hanisch… - … therapies in medicine, 2008 - Elsevier
… Christian Schneider was the principal investigator. Prof. Berthold Schneider advised on the
design of the protocol, and participated in data collection. Dr. Juergen Hanisch and Michael …

Safety and efficacy of the long-term adjuvant treatment of primary intermediate-to high-risk malignant melanoma (UICC/AJCC stage II and III) with a standardized …

…, J Hanisch, M Karasmann, B Schneider - …, 2005 - thieme-connect.com
Mistletoe therapy is the most frequently used complementary treatment in cancer patients in
Germany and Switzerland. However, its safety and efficacy were controversially discussed, …

Treatment of vertigo with a homeopathic complex remedy compared with usual treatments

B Schneider, P Klein, M Weiser - Arzneimittelforschung, 2005 - thieme-connect.com
The increasing interest in alternative medical practices has led to a number of controlled
studies on herbal and homeopathic agents. This paper presents the results of a meta-analysis …

[PDF][PDF] Liver sinusoidal endothelial cells contribute to CD8 T cell tolerance toward circulating carcinoembryonic antigen in mice

…, A Türler, M Overhaus, A Knoblich, B Schneider… - …, 2012 - Wiley Online Library
Immunity against cancer is impeded by local mechanisms promoting development of tumor‐specific
T cell tolerance, such as regulatory T cells, myeloid‐derived suppressor cells, or …

Intravenous recombinant tissue plasminogen activator (rt-PA) and urokinase in acute myocardial infarction: results of the German Activator Urokinase Study (GAUS)

…, G Alber, A Sheikhzadeh, B Schneider - Journal of the American …, 1988 - Elsevier
The effects of recombinant tissue plasminogen activator (rt-PA) and urokinase on patency
and early reocclusion of infarct-related coronary arteries were investigated in a single blind, …

Efficacy and safety of a herbal medicinal product containing myrrh, chamomile and coffee charcoal for the treatment of gastrointestinal disorders: a non-interventional …

U Albrecht, V Müller, B Schneider… - BMJ open …, 2014 - bmjopengastro.bmj.com
Objective This prospective observational postmarketing multicentre study was performed to
collect data on the clinical efficacy, safety and tolerability of a licensed herbal combination of …

Impact of complementary oral enzyme application on the postoperative treatment results of breast cancer patients–results of an epidemiological multicentre …

…, E Rethfeldt, PR Bock, J Hanisch, B Schneider - Cancer chemotherapy …, 2001 - Springer
Purpose: To evaluate the impact of postoperative treatment with an oral enzyme (OE)
preparation given complementary to an antineoplastic therapy in patients with breast cancer. …